Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study

The need for markers and predictors of Rituximab treatment resistance

(2014) Cassian Sitaru et al.   EXPERIMENTAL DERMATOLOGY

A Guide to Rational Dosing of Monoclonal Antibodies

(2012) Shuang Bai et al.   CLINICAL PHARMACOKINETICS

Rituximab in pemphigus

(2012) AmrinderJ Kanwar et al.   Indian Journal of Dermatology Venereology & Leprology

Childhood pemphigus vulgaris successfully treated with rituximab

(2012) AmrinderJ Kanwar et al.   Indian Journal of Dermatology Venereology & Leprology

Rituximab treatment of severe pemphigus: Long-term results including immunologic follow-up

(2012) Ziad Reguiai et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Therapy with rituximab for autoimmune pemphigus: Results from a single-center observational study on 42 cases with long-term follow-up

(2012) Giuseppe Cianchini et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: A retrospective study of 47 patients

(2012) Yael A. Leshem et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy

(2011) R.J. Feldman et al.   BRITISH JOURNAL OF DERMATOLOGY

Low-dose rituximab is effective in pemphigus

(2011) B. Horváth et al.   BRITISH JOURNAL OF DERMATOLOGY

Current therapy of the pemphigus group

(2011) Michael Kasperkiewicz et al.   CLINICS IN DERMATOLOGY

Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris

(2011) Emma E. Craythorne et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efficacy and safety of rituximab treatment in Indian pemphigus patients

(2011) A.J. Kanwar et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Rituximab in Childhood Pemphigus Vulgaris: A Long-Term Follow-Up Case and Review of the Literature

(2010) Irene Fuertes et al.   DERMATOLOGY

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)

(2010) A. Rubbert-Roth et al.   RHEUMATOLOGY

Rituximab in Severe Pemphigus

(2009) Enno Schmidt et al.   Annals of the New York Academy of Sciences

ELISA Testing of Anti–Desmoglein 1 and 3 Antibodies in the Management of Pemphigus

(2009) Claire Abasq et al.   ARCHIVES OF DERMATOLOGY

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

(2008) Dedee F. Murrell et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY